In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘BreastCancer’ clear

  • Dr. Eric Winer served as chair for a panel that developed the second international guidelines for management of advanced breast cancer.

     

Tags: BreastCancer

  • Dr. J. Dirk Iglehart comments that he now performs about a 10th of the number of mastectomies as when he entered the field in the 1970s.

Tags: BreastCancer, Surgery

  • A study from Dana-Farber scientists and other researchers shows most deaths from breast cancer occur in younger women who do not receive regular mammograms.

Tags: BasicResearch, BreastCancer

  • Dana-Farber patient Peter Devereaux and his oncologist, Kathryn Ruddy, MD, MPH, were featured in a story on NBC.com about male breast cancer. Devereaux is one of several marines who developed breast cancer after serving in Camp Lejeune in North Carolina.

Tags: BreastCancer

  • Dr. Gabriel Brooks commented on a new study showing Medicare spending for patients with advanced cancer is not linked to differences in survival.

Tags: BreastCancer, ColonCancer, LungCancer, PancreaticCancer, ProstateCancer, Survivorship

  • Dr. Andrea Richardson and colleagues have identified a genetic marker that may predict which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.

Tags: BreastCancer, Genomics, OvarianCancer, GynecologicCancers

  • Extending tamoxifen treatment to 10 years significantly improved a women's chances of surviving breast cancer and reduced the risk of the cancer coming back, a new study shows. Dr. Eric Winer said while only about 10 percent of women in the study were premenopausal, the benefits were similar to those for women after menopause, indicating that a new long-term strategy is now an option for them. (Full article requires a subscription)

Tags: BreastCancer, Hormones, Prevention

  • Dr. Eric Winer comments on the FDA's recent approval of the breast cancer drug Kadcyla. He says clinical trials show that the drug is both highly effective and has few side effects.

Tags: BreastCancer

  • Dr. Ursula Matulonis commented on a study that found women with BRCA-1 mutations can reduce their risk of breast and ovarian cancer if they get their ovaries removed by age 35.

Tags: BreastCancer, OvarianCancer, Genetics

  • Several studies published in Nature have identified 74 new genetic risk factors associated with three major cancers: breast, ovarian, and prostate. Dr. Philip Kantoff said it is unclear what this means for patients clinically, but the hope is that it will lead to more sophisticated screening and treatment strategies.

Tags: BasicResearch, BreastCancer, OvarianCancer, ProstateCancer, Genetics, GynecologicCancers

Showing 21-30 of 69 items